Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Griffin Hospital operates as an award-winning community teaching hospital with national recognition for patient-centered care and clinical excellence. It has been named one of Newsweek’s World’s Best Hospitals for seven consecutive years and has received numerous quality awards including from Fortune Magazine and The Joint Commission. It serves over 130,000 residents in Connecticut’s Lower Naugatuck Valley Region with a wide range of inpatient and outpatient services including advanced surgical techniques, comprehensive cancer care affiliated with Yale-New Haven Health System, mental health crisis intervention via the new EmPATH unit opening in late 2025, bariatrics, orthopedics, maternity/childbirth services and more. The hospital emphasizes the Planetree model of person-centered healthcare.
No drug development pipeline; all programs are clinical service lines.
Pipeline breadth reflects major service lines rather than R&D programs.
Three out of four patients treated in its new EmPATH mental health unit are stabilized within 24 hours.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Griffin Hospital.